Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer
暂无分享,去创建一个
E. Mittendorf | A. Philips | G. Peoples | J. Litton | G. Clifton | N. Qiao | T. Vreeland | G. Alatrash | D. Hale | R. Murthy | J. P. Holmes | Annelies T Hickerson | J. Lukas | J. Holmes